Key points are not available for this paper at this time.
Declining treatment negatively affects health outcomes among patients with cancer. Limited research has investigated national trends of and factors associated with treatment declination or its association with overall survival (OS) among patients with breast cancer.
Freeman et al. (Thu,) studied this question.